• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

by Glenn S. Demby | Jul 11, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting

by Glenn S. Demby | Jun 14, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Thermo Fisher, Siemens Healthineers and DiaSorin Headline a Super Dynamic Month in Deal Making

Thermo Fisher, Siemens Healthineers and DiaSorin Headline a Super Dynamic Month in Deal Making

by Glenn S. Demby | May 19, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Antitrust Regulators Derail Plans for Illumina-Grail Cancer Genomics Powerhouse

Antitrust Regulators Derail Plans for Illumina-Grail Cancer Genomics Powerhouse

by Glenn S. Demby | May 6, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

M&A Report: Roche Merges with GenMark Diagnostics to Create Syndromic Testing Powerhouse

by Glenn S. Demby | Apr 22, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com